Literature DB >> 7706212

Immunologically and enzymatically distinct rat choline kinase isozymes.

T Uchida1.   

Abstract

The purification and characterization of choline kinase R1 expressed in Escherichia coli, using expression plasmid pKCK(H) constructed with rat liver choline kinase cDNA [Uchida, T. and Yamashita, S. (1992) J. Biol. Chem. 267, 10156-10162], were carried out. Choline kinase R1 was chromatographically, enzymatically, and immunologically distinct from rat brain choline kinase [Uchida, T. and Yamashita, S. (1990) Biochim. Biophys. Acta 1043, 281-288]. This report, for the first time, definitively demonstrates the presence of two types of choline kinase isozymes. Rat choline kinase was immunologically classified into choline kinases P and R. Choline kinase P was purified from rat brain as described previously. Choline kinase R was designated as the choline kinase generated from the choline kinase R gene for choline kinase R1. Choline kinases from cytosol were chromatographically separated into two fractions, that is, one passed through a Blue-Toyopearl column and the other was retained on it. The choline kinase retained on the Blue-Toyopearl column was highly purified from rat liver cytosol and characterized in this study, being found to comprise isoforms of choline kinase R, and a choline kinase which was immunologically similar to choline kinase P. Choline kinases P and R are co-distributed in rat tissues. The carcinogen, 3-methylcholanthrene, and hepatotoxic carbon tetrachloride increased the enzyme activity, and the transcript and protein levels of choline kinase R in rat liver. The relation of choline kinase isozymes to previously purified enzymes was discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7706212     DOI: 10.1093/oxfordjournals.jbchem.a124670

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  4 in total

1.  Choline kinase β mutant mice exhibit reduced phosphocholine, elevated osteoclast activity, and low bone mass.

Authors:  Jasreen Kular; Jennifer C Tickner; Nathan J Pavlos; Helena M Viola; Tamara Abel; Bay Sie Lim; Xiaohong Yang; Honghui Chen; Robert Cook; Livia C Hool; Ming Hao Zheng; Jiake Xu
Journal:  J Biol Chem       Date:  2014-12-01       Impact factor: 5.157

2.  Increased choline kinase activity and elevated phosphocholine levels in human colon cancer.

Authors:  K Nakagami; T Uchida; S Ohwada; Y Koibuchi; Y Suda; T Sekine; Y Morishita
Journal:  Jpn J Cancer Res       Date:  1999-04

3.  Increased choline kinase activity in 1,2-dimethylhydrazine-induced rat colon cancer.

Authors:  K Nakagami; T Uchida; S Ohwada; Y Koibuchi; Y Morishita
Journal:  Jpn J Cancer Res       Date:  1999-11

4.  Phosphorylation of Human Choline Kinase Beta by Protein Kinase A: Its Impact on Activity and Inhibition.

Authors:  Ching Ching Chang; Ling Ling Few; Manfred Konrad; Wei Cun See Too
Journal:  PLoS One       Date:  2016-05-05       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.